tiletamine has been researched along with lactic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Constable, PD; Ko, JC; Krimins, RA; Payton, ME; Weil, AB | 1 |
| Ahn, JH; Choi, SC; Min, YG; Park, EJ | 1 |
1 trial(s) available for tiletamine and lactic acid
| Article | Year |
|---|---|
Hemodynamic effects in dogs after intramuscular administration of a combination of dexmedetomidine-butorphanol-tiletamine-zolazepam or dexmedetomidine-butorphanol-ketamine.
Topics: Analgesia; Animals; Blood Pressure; Bradycardia; Butorphanol; Cardiac Output; Cross-Over Studies; Dexmedetomidine; Dogs; Drug Combinations; Female; Injections, Intramuscular; Ketamine; Lactic Acid; Male; Oxygen Consumption; Respiration; Tiletamine; Vascular Resistance; Zolazepam | 2012 |
1 other study(ies) available for tiletamine and lactic acid
| Article | Year |
|---|---|
Repetitive TASER X26 discharge resulted in adverse physiologic events with a dose-response relationship related to the duration of discharge in anesthetized swine model.
Topics: Anesthetics; Animals; Bicarbonates; Blood Pressure; Cardiac Output; Drug Combinations; Electric Stimulation; Heart Rate; Hydrogen-Ion Concentration; Lactic Acid; Models, Animal; Oxygen Consumption; Swine; Tiletamine; Vascular Resistance; Zolazepam | 2013 |